Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 201–300 of 1,004
Genetic advances in autism: heterogeneity and convergence on shared pathways
Bill, B. R., & Geschwind, D. H. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.004 · Cited by 164
“For example, Phelan-McDermid Syndrome defined by deletions of 22q13 overlaps with deletions and duplications of the gene SHANK3, an ASCG [29].”
Lionel, A. C., Vaags, A. K., Sato, D., Gazzellone, M. J., Mitchell, E. B., Chen, H. Y., Costain, G., Walker, S., Egger, G., Thiruvahindrapuram, B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt056 · Cited by 162
“2 as well as at individual genes such as CNTNAP2, NRXN1 and SHANK3 (21,29,84,85).”
BackgroundLionel, A. C., Tammimies, K., Vaags, A. K., Rosenfeld, J. A., Ahn, J. W., Merico, D., Noor, A., Runke, C. K., Pillalamarri, V. K., Carter, M. T., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt669 · Cited by 163
The genetics of child psychiatric disorders: focus on autism and Tourette syndrome
State, M. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.004 · Cited by 162
“3 microdeletion syndrome region (Figure 3; Durand et al., 2007; Gauthier et al., 2009; Lim et al., 1999; Moessner et al., 2007).”
BackgroundEpilepsy and autism spectrum disorders: are there common developmental mechanisms?
Brooks-Kayal, A. (2010) · Brain and Development · doi:10.1016/j.braindev.2010.04.010 · Cited by 162
“Mutations in neuroli- gin-1, 3 and -4 have been identified in human patients with ASDs [33,34].”
BackgroundBerkel, S., Tang, W., Treviño, M., Vogt, M., Obenhaus, H. A., Gass, P., Scherer, S. W., Sprengel, R., Schratt, G., & Rappold, G. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr470 · Cited by 162
“Although SHANK3 mutations have been shown to cause ASD, ID and schizophrenia (21,22), Shank1 has not been associated with any disease phenotype yet.”
Behavioral profiles of mouse models for autism spectrum disorders
Ey, E., Leblond, C. S., & Bourgeron, T. (2011) · Autism Research · doi:10.1002/aur.175 · Cited by 161
Self-citationUsing zebrafish to assess the impact of drugs on neural development and function
Guo, S. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902988464 · Cited by 160
“3) Analyses of de novo chromosomal deletions and duplications have hinted at the involvement of synaptic molecules including neuroligins 3 and 4 (NLGN3 and NLGN4) [78], SHANK3 (a cytoplasmic binding partner of neuroligins) [79], neurexin (NRXN1) [80], contactin associated protein-like 2 (CNTNAP2, a member of neurexin…”
BackgroundKolevzon, A., Angarita, B., Bush, L., Wang, A. T., Frank, Y., Yang, A., Rapaport, R., Saland, J., Srivastava, S., Farrell, C., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-39 · Cited by 159
“In PMS, as patients age, they may be at increased risk for atypical bipolar disorder [29,42,43], and significant regression has also been reported in language, behavioral symptoms, motor skills, and self-help skills [2,29,37,42,43,62].”
BackgroundInfluentialBehavioral neuroscience of autism
Takumi, T., Tamada, K., Hatanaka, F., Nakai, N., & Bolton, P. F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.012 · Cited by 158
Ras and Rap Signaling in Synaptic Plasticity and Mental Disorders
Stornetta, R. L., & Zhu, J. J. (2011) · The Neuroscientist · doi:10.1177/1073858410365562 · Cited by 158
CRISPR/Cas9-induced shank3b mutant zebrafish display autism-like behaviors
Liu, C.-X., Li, C.-Y., Hu, C.-C., Wang, Y., Lin, J., Jiang, Y.-H., Li, Q., & Xu, X. (2018) · Molecular Autism · doi:10.1186/s13229-018-0204-x · Cited by 158
Multiple rare variants in the etiology of autism spectrum disorders
Buxbaum, J. D. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.1/jdbuxbaum · Cited by 158
“A recent study asked whether mutations in SHANK3 or chromosomal changes at the SHANK3 locus were directly associated with idiopathic ASDs, making use of FISH analysis and/or direct sequencing in about 300 cases.(48) The study identified three families with ASD that showed alterations: a family with a proband carrying…”
BackgroundHu, V. W., Nguyen, A., Kim, K. S., Steinberg, M. E., Sarachana, T., Scully, M. A., Soldin, S. J., Luu, T., & Lee, N. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005775 · Cited by 158
“The respective genes include glutamate receptors, GABA receptors, neuroligins, neurexin 1, and SHANK3 which are involved in synapse formation and function [36–41], and RELN, ROBO1/2, SLIT2, ITGB1, PAK, and MET which are involved in axon guidance [18,42–44].”
BackgroundGenetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications
Yoo, H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.257 · Cited by 158
“3 were identified in probands and families with ASD in many studies [50].”
BackgroundInfluentialBrain connectivity in autism spectrum disorder
Mohammad-Rezazadeh, I., Frohlich, J., Loo, S. K., & Jeste, S. S. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000301 · Cited by 157
Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate
Irie, F., Badie-Mahdavi, H., & Yamaguchi, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117881109 · Cited by 153
“Mice were tested for their ability to hang from a wire cage lid (4).”
BackgroundMethodInfluentialJaramillo, T. C., Speed, H. E., Xuan, Z., Reimers, J. M., Liu, S., & Powell, C. M. (2016) · Autism Research · doi:10.1002/aur.1529 · Cited by 153
“…contributors to the behavioral and biological alterations associated with ASD and PhelanMcDermid (22q13 Deletion) Syndrome [Boccuto et al., 2013; Durand et al., 2007; Gauthier et al., 2009; Kolevzon et al., 2011; Moessner et al., 2007; Naisbitt et al., 1999; Tu et al., 1999; Turner 1999; Waga…”
BackgroundInfluentialCLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
Bidinosti, M., Botta, P., Krüttner, S., Proenca, C. C., Stoehr, N., Bernhard, M., Fruh, I., Mueller, M., Bonenfant, D., Voshol, H., et al. (2016) · Science · doi:10.1126/science.aad5487 · Cited by 151
Bhandari, R., Paliwal, J. K., & Kuhad, A. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_4 · Cited by 197
Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder
Yoon, S., Choi, J., Lee, W., & Do, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040966 · Cited by 149
“On the other hand, an additional copy of 22q13/SHANK3 did not display ASD symptoms, such as language and social communication impairment [95,97,174,175].”
BackgroundMirabella, F., Desiato, G., Mancinelli, S., Fossati, G., Rasile, M., Morini, R., Markicevic, M., Grimm, C., Amegandjin, C. A., Termanini, A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.006 · Cited by 160
Laumonnier, F., Shoubridge, C., Antar, C., Nguyen, L. S., Esch, H. V., Kleefstra, T., Briault, S., Fryns, J. P., Hamel, B., Chelly, J., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.14 · Cited by 174
Autism genetics: strategies, challenges, and opportunities
O'Roak, B. J., & State, M. W. (2008) · Autism Research · doi:10.1002/aur.3 · Cited by 150
“Two recent reports have found a variety of de novo and inherited mutations at the gene SH3 and multiple ankyrin repeat domains 3 (SHANK3) among individuals with ASD [Durand et al., 2007; Moessner et al., 2007].”
BackgroundCurrent knowledge on the genetics of autism and propositions for future research
Bourgeron, T. (2016) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2016.05.004 · Cited by 149
“This approach was successful in identifying several synaptic genes associated with ASD such as NLGN3 , NLGN4X and SHANK3 [10,11].”
BackgroundSelf-citationA novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD)
Adegbola, A., Gao, H., Sommer, S., & Browning, M. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32142 · Cited by 148
“Genetic lesions associated with autism susceptibility have included allelic polymorphisms in the EN-2, HRAS, SCN2A, and APC genes [Hérault et al., 1993; Petit et al., 1995; Weiss et al., 2003; Zhou et al., 2007], mutations in NLGN4X and NLGN3 [Yan et al., 2005], neurexin 1-beta [Chubykin et al., 2005; Feng et al., 20…”
BackgroundEpigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders
Zhu, L., Wang, X., Li, X.-L., Towers, A., Cao, X., Wang, P., Bowman, R., Yang, H., Goldstein, J., Li, Y.-J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt547 · Cited by 147
“However, many of these transcripts have not been fully characterized (18,33).”
Lee, J., Chung, C., Ha, S., Lee, D., Kim, D.-Y., Kim, H., & Kim, E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00094 · Cited by 147
“…including autism spectrum disorders (ASDs), Phelan-McDermid syndrome, schizophrenia, and intellectual disability (Bonaglia et al., 2001, 2011; Durand et al., 2007; Moessner et al., 2007; Berkel et al., 2010; Gauthier et al., 2010; Hamdan et al., 2011; Leblond et al., 2012, 2014; Boccuto et…”
BackgroundGenetics of autism spectrum disorders
Kumar, R. A., & Christian, S. L. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0029-2 · Cited by 169
“Several studies have reported SHANK3 mutations in unrelated autism families [ 21 ,22].”
BackgroundCerebellar associative sensory learning defects in five mouse autism models
Kloth, A. D., Badura, A., Li, A., Cherskov, A., Connolly, S. G., Giovannucci, A., Bangash, M. A., Grasselli, G., Peñagarikano, O., Piochon, C., et al. (2015) · eLife · doi:10.7554/elife.06085 · Cited by 145
Alterations in CDH15 and KIRREL3 in Patients with Mild to Severe Intellectual Disability
Bhalla, K., Luo, Y., Buchan, T., Beachem, M. A., Guzauskas, G. F., Ladd, S., Bratcher, S. J., Schroer, R. J., Balsamo, J., DuPont, B. R., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.10.020 · Cited by 143
Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice
Vicidomini, C., Ponzoni, L., Lim, D., Schmeisser, M. J., Reim, D., Morello, N., Orellana, D., Tozzi, A., Durante, V, Scalmani, P., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.30 · Cited by 144
Self-citationIMGSAC, Maestrini, E., Pagnamenta, A. T., Lamb, J. A., Bacchelli, E., Sykes, N. H., Sousa, I., Toma, C., Barnby, G., Butler, H., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.34 · Cited by 143
Deregulation of EIF4E: a novel mechanism for autism
Neves-Pereira, M., Müller, B., Massie, D., Williams, J. H. G., O’Brien, P. C. M., Hughes, A., Shen, S.-B., Clair, D. S., & Miedzybrodzka, Z. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066852 · Cited by 142
Convulsing toward the pathophysiology of autism
Tuchman, R., Moshé, S. L., & Rapin, I. (2009) · Brain and Development · doi:10.1016/j.braindev.2008.09.009 · Cited by 142
“There are increasing numbers of reports of families or individuals with autism who lack genes important in synapse development and maintenance of synapse function [106], including mutations in the gene encoding the synaptic scaffolding protein SHANK3 [107], and in neuroligins which are synaptic cell adhesion molecules…”
BackgroundA pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
Kolevzon, A., Bush, L., Wang, A., Halpern, D., Frank, Y., Grodberg, D., Rapaport, R., Tavassoli, T., Chaplin, W., Soorya, L., et al. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-54 · Cited by 140
“5% of ASD cases [1-4].”
Speed, H. E., Kouser, M., Xuan, Z., Reimers, J. M., Ochoa, C. F., Gupta, N., Liu, S., & Powell, C. M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3125-14.2015 · Cited by 140
“This premature stop codon in exon 21 led to predictions of a truncated Shank3 protein (Durand et al., 2007, 2012).”
BackgroundInfluentialEy, E., Torquet, N., Le Sourd, A.-M., Leblond, C. S., Boeckers, T. M., Faure, P., & Bourgeron, T. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.031 · Cited by 140
“For example, an increasing number of studes highlights the association between ASD and mutations in he post-synaptic scaffolding proteins SHANK1, PROSAP1/SHANK2 nd PROSAP2/SHANK3 (PROSAP2/SHANK3 [5–7]; PROSAP1/SHANK2 8–10]; SHANK1 [11]).”
Self-citationFragile X mental retardation 1 gene enhances the translation of large autism-related proteins
Greenblatt, E. J., & Spradling, A. C. (2018) · Science · doi:10.1126/science.aas9963 · Cited by 140
Genetic aspects of autism spectrum disorders: insights from animal models
Banerjee, S., Riordan, M., & Bhat, M. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00058 · Cited by 139
Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research
Rogers, T. D., McKimm, E., Dickson, P. E., Goldowitz, D., Blaha, C. D., & Mittleman, G. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00015 · Cited by 139
“In humans, the Shank3 gene is found at chromosome 22q13 and codes for a structural protein necessary for the maintenance and plasticity of postsynaptic densities located in excitatory synapses (Boeckers et al., 2002; Durand et al., 2007).”
BackgroundA mouse model of the human Fragile X syndrome I304N mutation
Zang, J. B., Nosyreva, E. D., Spencer, C. M., Volk, L. J., Musunuru, K., Zhong, R., Stone, E. F., Yuva-Paylor, L. A., Huber, K. M., Paylor, R., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000758 · Cited by 138
“in genes including neuroligin-3 [1,2], neurexin-1 [3], shank 3 [4],”
Background22q13.3 deletion syndrome: clinical and molecular analysis using array CGH
Dhar, S. U., del Gaudio, D., German, J. R., Peters, S. U., Ou, Z., Bader, P. I., Berg, J. S., Blazo, M., Brown, C. W., Graham, B. H., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33253 · Cited by 138
“, 2003] and SHANK3 on chromosome 22q13 [Durand et al., 2007] are monogenic causes of autism spectrum disorders. In one study of 400 unrelated subjects with autism spectrum disorder, one de novo mutation and two gene deletions of the SHANK3 gene were discovered, contributing 0.75% causality to this cohort [Moessner et…”
InfluentialEpigenetic Regulations in Neuropsychiatric Disorders
Kuehner, J. N., Bruggeman, E. C., Wen, Z., & Yao, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00268 · Cited by 136
Xu, X., Li, C., Gao, X., Xia, K., Guo, H., Li, Y., Hao, Z., Zhang, L., Gao, D., Xu, C., et al. (2018) · Cell Research · doi:10.1038/cr.2017.132 · Cited by 133
High rate of disease-related copy number variations in childhood onset schizophrenia
Ahn, K., Gotay, N., Andersen, T. M., Anvari, A. A., Gochman, P., Lee, Y., Sanders, S., Guha, S., Darvasi, A., Glessner, J. T., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.59 · Cited by 132
A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB
Need, A. C., Attix, D. K., McEvoy, J. M., Cirulli, E. T., Linney, K. L., Hunt, P., Ge, D., Heinzen, E. L., Maia, J. M., Shianna, K. V., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp413 · Cited by 133
“Rare genetic variants affecting SHANK3 have been associated with autism (61,84,85) and possibly epilepsy (61) IED EDS errors 743 ESL, site 1.”
BackgroundWei, H., Alberts, I. L., & Li, X. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.025 · Cited by 154
“…including NRXN1, NLGN3/4, SHANK3, as well as mutations in synaptic proteins, including CNTNAP2, CACNA1C, CNTN3/4 and PCDH9/10, in autistic subjects (Durand et al., 2007; Abrahams and Geschwind, 2008; Alarcon et al., 2008; Arking et al., 2008; Bakkaloglu et al., 2008; Kim et al., 2008; Marshall et…”
BackgroundSHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras
Lilja, J., Zacharchenko, T., Georgiadou, M., Jacquemet, G., Franceschi, N. D., Peuhu, E., Hamidi, H., Pouwels, J., Martens, V., Nia, F. H., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3487 · Cited by 132
“Sparse matrix crystal screening of SHANK3 (1-348) was performed using an innovadyne nanodrop screen maker at protein concentration of 6mgml−1 with a 200 nl drop size (1:1 ratio) using sitting drop vapour diffusion.”
MethodSelf-citationVeenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
“Maternal duplication of chromosome 15q11-q13 (Christian et al, 2008; Cook et al, 1997) Deletions or duplications of chromosome 16p11 (Kumar et al, 2008; Weiss et al, 2008) NLGN4X (Jamain et al, 2003) NLGN3 (Jamain et al, 2003) SHANK3 (Durand et al, 2007) SHANK2 (Berkel et al, 2010) NRXN1 (Bucan et al, 2009; Glessner e…”
Stamou, M., Streifel, K. M., Goines, P. E., & Lein, P. J. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.12.001 · Cited by 128
“…CNTNAP2 (CNTNAP2) and Shank3 (SHANK3), are overrepresented in ASD compared to neurotypical children (Alarcon et al., 2008; Arking et al., 2008; Bakkaloglu et al., 2008; Durand et al., 2007; Jamain et al., 2003; Kim et al., 2008; Laumonnier et al., 2004; Szatmari et al., 2007; Yan et al., 2005).”
BackgroundBoissart, C., Poulet, A., Georges, P., Darville, H., Julita, E., Delorme, R., Bourgeron, T., Peschanski, M., & Benchoua, A. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.71 · Cited by 128
Self-citationGene Expression in Cortical Interneuron Precursors is Prescient of their Mature Function
Batista-Brito, R., Machold, R., Klein, C., & Fishell, G. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm258 · Cited by 128
Sestan, N., & State, M. W. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.015 · Cited by 127
Progress in Understanding Autism: 2007–2010
Rutter, M. L. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1184-2 · Cited by 191
“There are multiple replicated findings that autism is associated with rare pathogenic gene mutations such as neuroligins , neurexin and SHANK 3 (Persico and Bugeron 2006; Durand et al. 2007; Bourgeron 2007; Geschwind and Levitt 2007; Jamain et al. 2008).”
Backgroundde Bartolomeis, A., Latte, G., Tomasetti, C., & Iasevoli, F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8534-3 · Cited by 137
“Mutations in the gene coding for Shank3 have been reported in ASD patients [67, 107–109].”
BackgroundStephenson, J. R., Wang, X., Perfitt, T. L., Parrish, W. P., Shonesy, B. C., Marks, C. R., Mortlock, D. P., Nakagawa, T., Sutcliffe, J. S., & Colbran, R. J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2068-16.2017 · Cited by 127
“Approximately 10% of the 100 CaMKAPs specifically associated with synaptic CaMKII holoenzymes (Baucum et al., 2015) have been linked to ASD, including GluN2B; Shank-1, -2, and -3; SAPAP-1, -2, -3, -4; and Homer-1 (Durand et al., 2007; Berkel et al., 2010; Pinto et al., 2010; O’Roak et al., 2012; Sato et al., 2012).”
BackgroundRisk factors for autism: translating genomic discoveries into diagnostics
Scherer, S. W., & Dawson, G. (2011) · Human Genetics · doi:10.1007/s00439-011-1037-2 · Cited by 144
“…sequencing projects in ASD and related disorders are also generating new Wndings (Addington et al. 2011; Bakkaloglu et al. 2008; Berkel et al. 2010; Durand et al. 2007; Fassio et al. 2011; Gauthier et al. 2011; Hamdan et al. 2010, 2011; Jamain et al. 2003; Kumar et al. 2009; Laumonnier et al.…”
BackgroundInfluentialDevelopmental vulnerability of synapses and circuits associated with neuropsychiatric disorders
Penzes, P., Buonanno, A., Passafaro, M., Sala, C., & Sweet, R. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12261 · Cited by 125
Merner, N. D., Chandler, M. R., Bourassa, C. V., Liang, B., Khanna, A. R., Dion, P. A., Rouleau, G. A., & Kahle, K. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00386 · Cited by 143
“, 2001) have been found in both ID and ASD; and, mutations in SHANK3 [OMIM 606230] have been identified in ASD (Durand et al., 2007), SCZ (Gauthier et al.”
BackgroundOberman, L. M., Boccuto, L., Cascio, L., Sarasua, S., & Kaufmann, W. E. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0323-9 · Cited by 124
“One such risk gene is the SH3 and multiple ankyrin repeat domains 3 (SHANK3) gene [3–5], which lies on the distal long arm of chromosome 22 and whose protein product (by the same name) acts as a scaffolding protein in its interactions with various synaptic molecules, including * Correspondence: loberman@lifespan.”
BackgroundGenotype–phenotype relationship in three cases with overlapping 19p13.12 microdeletions
Bonaglia, M. C., Marelli, S., Novara, F., Commodaro, S., Borgatti, R., Minardo, G., Memo, L., Mangold, E., Beri, S., Zucca, C., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.115 · Cited by 134
Changes in Plasticity Across the Lifespan
Oberman, L., & Pascual-Leone, A. (2013) · Progress in Brain Research · doi:10.1016/b978-0-444-63327-9.00016-3 · Cited by 124
“A functionally “normal” brain is thus a changing brain, a brain whose capacity and mechanisms of change are shifting appropriately from one time point to another in a given individual’s life.”
BackgroundDeletion of Glutamate Delta-1 Receptor in Mouse Leads to Aberrant Emotional and Social Behaviors
Yadav, R., Gupta, S. C., Hillman, B. G., Bhatt, J. M., Stairs, D. J., & Dravid, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032969 · Cited by 123
The over‐pruning hypothesis of autism
Thomas, M. S. C., Davis, R., Karmiloff‐Smith, A., Knowland, V. C. P., & Charman, T. (2016) · Developmental Science · doi:10.1111/desc.12303 · Cited by 123
Potential serum biomarkers from a metabolomics study of autism
Wang, H., Liang, S., Wang, M., Gao, J., Sun, C., Wang, J., Xia, W., Wu, S., Sumner, S. J., Zhang, F., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140009 · Cited by 123
Genetic causes of syndromic and non‐syndromic autism
CAGLAYAN, A. O. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2009.03523.x · Cited by 123
“The SHANK3 gene may be responsible for at least part of the phenotype, such as developmental delay and speech deficits.(59)”
BackgroundPhelan–McDermid Syndrome and SHANK3: Implications for Treatment
Costales, J. L., & Kolevzon, A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0352-z · Cited by 147
“Patients with PMS are also commonly affected by ID, with approximately 75 % of patients showing severe-to-profound intellectual deficits [10, 11, 38, 50].”
BackgroundSynaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders?
Yan, Z., Kim, E., Datta, D., Lewis, D. A., & Soderling, S. H. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2360-16.2016 · Cited by 120
“…a synaptic scaffolding protein at glutamatergic synapses (Naisbitt et al., 1999; Sheng and Kim, 2000; Hayashi et al., 2009), is one of the most prevalent and highly penetrant monogenic causes of autism (Bonaglia et al., 2001; Durand et al., 2007; Sebat et al., 2007; Betancur and Buxbaum, 2013).”
BackgroundSpooren, W., Lindemann, L., Ghosh, A., & Santarelli, L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.09.004 · Cited by 119
An endocannabinoid-regulated basolateral amygdala–nucleus accumbens circuit modulates sociability
Folkes, O. M., Báldi, R., Kondev, V., Marcus, D. J., Hartley, N. D., Turner, B. D., Ayers, J. K., Baechle, J. J., Misra, M. P., Altemus, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131752 · Cited by 119
“the genetic findings commonly presented in patients (33, 35-38).”
BackgroundJaramillo, T. C., Speed, H. E., Xuan, Z., Reimers, J. M., Escamilla, C. O., Weaver, T. P., Liu, S., Filonova, I., & Powell, C. M. (2017) · Autism Research · doi:10.1002/aur.1664 · Cited by 119
Chen, S. X., Tari, P. K., She, K., & Haas, K. Z. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.016 · Cited by 151
Santini, E., & Klann, E. (2014) · Science Signaling · doi:10.1126/scisignal.2005832 · Cited by 118
Genome‐wide Association Study of Autism Spectrum Disorder in the East Asian Populations
Liu, X., Shimada, T., Otowa, T., Wu, Y., Kawamura, Y., Tochigi, M., Iwata, Y., Umekage, T., Toyota, T., Maekawa, M., et al. (2016) · Autism Research · doi:10.1002/aur.1536 · Cited by 118
“…led to many important discoveries and identified a number of causal or susceptibility genes to ASD, including NLGN4X [Jamain et al., 2003], SHANK3 [Durand et al., 2006], CNTNAP2 [Alarcon et al., 2008], NRXN1 [Kim et al., 2008], and OXTR [Wu et al., 2005, Liu et al., 2010], as well as ASD…”
BackgroundInfluential22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome?
Okamoto, N., Kubota, T., Nakamura, Y., Murakami, R., Nishikubo, T., Tanaka, I., Takahashi, Y., Hayashi, S., Imoto, I., Inazawa, J., et al. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31771 · Cited by 117
“E-mail: okamoto@osaka.email.ne.jp DOI 10.1002/ajmg.a.31771 SHANK3 gene were found in the patients with autism spectrum disorders [Durand et al., 2007].”
BackgroundInfluentialZebrafish models for the functional genomics of neurogenetic disorders
Kabashi, E., Brustein, E., Champagne, N., & Drapeau, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.011 · Cited by 141
Kelleher III, R. J., Geigenmüller, U., Hovhannisyan, H., Trautman, E., Pinard, R., Rathmell, B., Carpenter, R., & Margulies, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035003 · Cited by 116
“The identification of HOMER1 as an autism risk gene adds an important component to the network of PSD proteins causally implicated in autism, which now includes the products of the SHANK2 [7,42], SHANK3 [23], NLGN3 [43], NLGN4 [43], SYNGAP1 [7], and DLGAP2 [7] genes (Fig.”
InfluentialSlitrks as emerging candidate genes involved in neuropsychiatric disorders
Proenca, C. C., Gao, K. P., Shmelkov, S. V., Rafii, S., & Lee, F. S. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.01.001 · Cited by 116
Bey, A. L., Wang, X., Yan, H., Kim, N., Passman, R. L., Yang, Y., Cao, X., Towers, A. J., Hulbert, S. W., Duffney, L. J., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0142-6 · Cited by 115
The multifaceted role of mitochondria in autism spectrum disorder
Khaliulin, I., Hamoudi, W., & Amal, H. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02725-z · Cited by 143
“We have produced a large-scale computational biology analysis of the SNO-proteome in the cortex of Shank3 mutant mice (a popular model of ASD [171, 282, 283]) and found that among the NO-related molecular alterations, the most prominent change was the activation of the mTOR signaling pathway [171,…”
Codagnone, M. G., Podestá, M. F., Uccelli, N. A., & Reinés, A. (2015) · Developmental Neuroscience · doi:10.1159/000375489 · Cited by 115
Shank3 Deficiency Induces NMDA Receptor Hypofunction via an Actin-Dependent Mechanism
Duffney, L. J., Wei, J., Cheng, J., Liu, W., Smith, K. R., Kittler, J. T., & Yan, Z. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1175-13.2013 · Cited by 115
The zebrafish subcortical social brain as a model for studying social behavior disorders
Geng, Y., & Peterson, R. T. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039446 · Cited by 129
“Knocking out the autism gene shank3b (Durand et al., 2007) induced deficits in shoaling, social preference and kin recognition (Liu et al.”
BackgroundRETRACTED: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism
Bangash, M. A., Park, J. M., Melnikova, T., Wang, D., Jeon, S. K., Lee, D., Syeda, S., Kim, J., Kouser, M., Schwartz, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.052 · Cited by 114
“Point mutations elsewhere in Shank3, for instance within the ankyrin repeats, are also associated with ASD but are typically less severe than mutations with loss of the Homer-binding domain (Durand et al., 2007).”
InfluentialRetractedMolecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex
Roll, P., Vernes, S. C., Bruneau, N., Cillario, J., Ponsole-Lenfant, M., Massacrier, A., Rudolf, G., Khalife, M., Hirsch, E., Fisher, S. E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq415 · Cited by 114
Kathuria, A., Nowosiad, P., Jagasia, R., Aigner, S., Taylor, R. D., Andreae, L. C., Gatford, N. J. F., Lucchesi, W., Srivastava, D. P., & Price, J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.185 · Cited by 130
Carmona, A., Roudeau, S., & Ortega, R. (2021) · Toxics · doi:10.3390/toxics9090198 · Cited by 127
“Nevertheless, the precise description of the molecular mechanisms of synaptic toxicity still remains largely unknown and their elucidation will allow the designing of adapted prevention strategies to treat or slow down the progression of devastating neurological diseases such as ASD and AD.”
InfluentialMutation screening of melatonin-related genes in patients with autism spectrum disorders
Jonsson, L., Ljunggren, E., Bremer, A., Pedersen, C., Landén, M., Thuresson, K., Giacobini, M., & Melke, J. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-10 · Cited by 113
“have been found to be causative or contributory factors for autism spectrum disorders [6-9].”
BackgroundCusco, I., Medrano, A., Gener, B., Vilardell, M., Gallastegui, F., Villa, O., Gonzalez, E., Rodriguez-Santiago, B., Vilella, E., Del Campo, M., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp092 · Cited by 113
“Schematic representation of the glutamatergic synapse and the postsynaptic neuronal signaling pathways relevant to ASD, with the putative location of the proteins encoded by the genes affected by the CNVs detected [(1) PIK3CB, (2) PIK3R4, (3) PIP5K3, (4) DLG2, (5) RAF1, (6) PDPK1, (7) CHRNA7, (8) AGXT2L2, (9) GRM8 and…”
BackgroundPagnamenta, A. T., Khan, H., Walker, S., Gerrelli, D., Wing, K., Bonaglia, M. C., Giorda, R., Berney, T., Mani, E., Molteni, M., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.079426 · Cited by 111
Autism spectrum disorders: an updated guide for genetic counseling
Griesi‐Oliveira, K., & Sertie, A. L. (2017) · Einstein (São Paulo) · doi:10.1590/s1679-45082017rb4020 · Cited by 273
“However, along the years, a considerable number of ASD individuals were found to harbor rare mutations, which have a damaging effect on neuronal development probably sufficient to be responsible for the disease by themselves.(7-10) Also, in some families, a same rare potentially damaging genetic variant is shared amon…”
BackgroundFunctional significance of rare neuroligin 1 variants found in autism
Nakanishi, M., Nomura, J., Ji, X., Tamada, K., Arai, T., Takahashi, E., Bućan, M., & Takumi, T. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006940 · Cited by 129
Kolozsi, E., Mackenzie, R. N., Roullet, F. I., Decatanzaro, D., & Foster, J. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.021 · Cited by 110
Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism
Pilorge, M., Fassier, C., Le Corronc, H., Potey, A., Bai, J., De Gois, S., Delaby, E., Assouline, B., Guinchat, V, Devillard, F., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.139 · Cited by 110
“Subjects Patients were recruited by the Paris Autism Research International Study (PARIS) at specialized clinical centers in France and Sweden.(29) All patients were evaluated by psychiatrists and diagnosed based on clinical evaluation and DSM-IV criteria.”
Self-citationLee, E.-J., Lee, H., Huang, T.-N., Chung, C., Shin, W., Kim, K., Koh, J.-Y., Hsueh, Y.-P., & Kim, E. (2015) · Nature Communications · doi:10.1038/ncomms8168 · Cited by 110
Children With Autism Show Reduced Somatosensory Response: An MEG Study
Marco, E. J., Khatibi, K., Hill, S. S., Siegel, B., Arroyo, M. S., Dowling, A. F., Neuhaus, J. M., Sherr, E. H., Hinkley, L. N. B., & Nagarajan, S. S. (2012) · Autism Research · doi:10.1002/aur.1247 · Cited by 109
“Furthermore, genes critical to the function of developing interneurons, such as Cntnap4, Sema3a, and Shank3 have been linked to autism through gene-linkage and genome-wide association studies (Durand et al., 2007; Sebat et al., 2007; Szatmari et al., 2007).”
BackgroundNeurobehavioral Profile and Brain Imaging Study of the 22q13.3 Deletion Syndrome in Childhood
Philippe, A., Boddaert, N., Vaivre-Douret, L., Robel, L., Danon-Boileau, L., Malan, V., de Blois, M.-C., Heron, D., Colleaux, L., Golse, B., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-2584 · Cited by 108
Ting, J. T., Peça, J., & Feng, G. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150442 · Cited by 108
“This finding is particularly interesting in light of the demonstrated interaction between SAPAPs and Shank3 (Boeckers et al. 1999b), with strong evidence implicating Shank3 mutations as causative in some ASD cases (Durand et al. 2007, Gauthier et al. 2009, Moessner et al. 2007).”
BackgroundWöhr, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.021 · Cited by 107
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.